  Motivation: The proliferation of Biomedical research articles has made the
task of information retrieval more important than ever. Scientists and
Researchers are having difficulty in finding articles that contain information
relevant to them. Proper extraction of biomedical entities like Disease,
Drug/chem, Species, Gene/protein, can considerably improve the filtering of
articles resulting in better extraction of relevant information. Performance on
BioNer benchmarks has progressively improved because of progression in
transformers-based models like BERT, XLNet, OpenAI, GPT2, etc. These models
give excellent results; however, they are computationally expensive and we can
achieve better scores for domain-specific tasks using other contextual
string-based models and LSTM-CRF based sequence tagger. Results: We introduce
BioNerFlair, a method to train models for biomedical named entity recognition
using Flair plus GloVe embeddings and Bidirectional LSTM-CRF based sequence
tagger. With almost the same generic architecture widely used for named entity
recognition, BioNerFlair outperforms previous state-of-the-art models. I
performed experiments on 8 benchmarks datasets for biomedical named entity
recognition. Compared to current state-of-the-art models, BioNerFlair achieves
the best F1-score of 90.17 beyond 84.72 on the BioCreative II gene mention
(BC2GM) corpus, best F1-score of 94.03 beyond 92.36 on the BioCreative IV
chemical and drug (BC4CHEMD) corpus, best F1-score of 88.73 beyond 78.58 on the
JNLPBA corpus, best F1-score of 91.1 beyond 89.71 on the NCBI disease corpus,
best F1-score of 85.48 beyond 78.98 on the Species-800 corpus, while near best
results was observed on BC5CDR-chem, BC3CDR-disease, and LINNAEUS corpus.
